Four-month-old with severe PIK3CA-related overgrowth spectrum disorder successfully treated with alpelisb.
Pediatr Dermatol
; 41(4): 714-717, 2024.
Article
em En
| MEDLINE
| ID: mdl-38444084
ABSTRACT
PIK3CA-related overgrowth spectrum (PROS) encompasses different clinical entities caused by somatic activating mutations in PIK3CA. Among PROS, CLOVES syndrome represents a severe phenotype with poor survival rate. We present the case of a 4-month-old girl with CLOVES syndrome successfully treated with alpelisib, a PIKC3A inhibitor.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Tiazóis
/
Classe I de Fosfatidilinositol 3-Quinases
Limite:
Female
/
Humans
/
Infant
Idioma:
En
Revista:
Pediatr Dermatol
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Chile
País de publicação:
Estados Unidos